Hubert Chen

Hubert Chen

Company: Metacrine

Job title: Chief Medical Officer


Dr. Chen is the Chief Medical Officer of Metacrine, a clinical-stage biopharmaceutical company building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal diseases. He previously served as Chief Scientific and Medical Officer of Pfenex, where he oversaw research & development and led multiple interactions with the US FDA, EMA and PMDA. Prior positions included vice president of clinical development at Aileron Therapeutics, vice president of translational medicine at Regulus Therapeutics, senior director of clinical research and corporate development at Amylin Pharmaceuticals, and associate director of medical sciences at Amgen. Dr. Chen was staff research investigator at the Gladstone Institutes and assistant professor at the University of California, San Francisco. He received his residency training at Massachusetts General Hospital, M.D. from Columbia University, and B.A.S. in political science and biology from Stanford University. Dr. Chen is board certified in both Internal Medicine and Endocrinology, Diabetes, and Metabolism.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.